AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58
APPETITE-SUPPRESSANT DRUGS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - IN-VITRO INHIBITION OF P450-2D6 BY D-FENFLURAMINE AND L-FENFLURAMINE, BUT NOT PHENTERMINE
Authors: VONMOLTKE LL GREENBLATT DJ CIRAULO DA GRASSI JM GRANDA BW DUAN SX HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., APPETITE-SUPPRESSANT DRUGS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - IN-VITRO INHIBITION OF P450-2D6 BY D-FENFLURAMINE AND L-FENFLURAMINE, BUT NOT PHENTERMINE, Journal of clinical psychopharmacology, 18(4), 1998, pp. 338-341
ALPRAZOLAM IS ANOTHER SUBSTRATE FOR HUMAN CYTOCHROME P450-3A ISOFORMS
Authors: VENKATAKRISHNAN K GREENBLATT DJ VONMOLTKE LL SHADER RI
Citation: K. Venkatakrishnan et al., ALPRAZOLAM IS ANOTHER SUBSTRATE FOR HUMAN CYTOCHROME P450-3A ISOFORMS, Journal of clinical psychopharmacology, 18(3), 1998, pp. 256-256
DRUG-INTERACTIONS WITH NEWER ANTIDEPRESSANTS - ROLE OF HUMAN CYTOCHROMES P450
Authors: GREENBLATT DJ VONMOLTKE LL HARMATZ JS SHADER RI
Citation: Dj. Greenblatt et al., DRUG-INTERACTIONS WITH NEWER ANTIDEPRESSANTS - ROLE OF HUMAN CYTOCHROMES P450, The Journal of clinical psychiatry, 59, 1998, pp. 19-27
PROTEASE INHIBITORS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - HIGH-RISK ASSOCIATED WITH RITONAVIR
Authors: VONMOLTKE LL GREENBLATT DJ GRASSI JM GRANDA BW DUAN SX FOGELMAN SM DAILY JP HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., PROTEASE INHIBITORS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - HIGH-RISK ASSOCIATED WITH RITONAVIR, Journal of clinical pharmacology, 38(2), 1998, pp. 106-111
5 DISTINCT HUMAN CYTOCHROMES MEDIATE AMITRIPTYLINE N-DEMETHYLATION IN-VITRO - DOMINANCE OF CYP 2C19 AND 3A4
Authors: VENKATAKRISHNAN K GREENBLATT DJ VONMOLTKE LL SCHMIDER J HARMATZ JS SHADER RI
Citation: K. Venkatakrishnan et al., 5 DISTINCT HUMAN CYTOCHROMES MEDIATE AMITRIPTYLINE N-DEMETHYLATION IN-VITRO - DOMINANCE OF CYP 2C19 AND 3A4, Journal of clinical pharmacology, 38(2), 1998, pp. 112-121
EFFECTS OF KETOCONAZOLE ON TRIAZOLAM PHARMACOKINETICS, PHARMACODYNAMICS AND BENZODIAZEPINE RECEPTOR-BINDING IN MICE
Authors: FAHEY JM PRITCHARD GA VONMOLTKE LL PRATT JS GRASSI JM SHADER RI GREENBLATT DJ
Citation: Jm. Fahey et al., EFFECTS OF KETOCONAZOLE ON TRIAZOLAM PHARMACOKINETICS, PHARMACODYNAMICS AND BENZODIAZEPINE RECEPTOR-BINDING IN MICE, The Journal of pharmacology and experimental therapeutics, 285(1), 1998, pp. 271-276
RELATIVE QUANTITIES OF CATALYTICALLY ACTIVE CYP 2C9 AND 2C19 IN HUMANLIVER-MICROSOMES - APPLICATION OF THE RELATIVE ACTIVITY FACTOR APPROACH
Authors: VENKATAKRISHNAN K VONMOLTKE LL GREENBLATT DJ
Citation: K. Venkatakrishnan et al., RELATIVE QUANTITIES OF CATALYTICALLY ACTIVE CYP 2C9 AND 2C19 IN HUMANLIVER-MICROSOMES - APPLICATION OF THE RELATIVE ACTIVITY FACTOR APPROACH, Journal of pharmaceutical sciences, 87(7), 1998, pp. 845-853
INHIBITION OF DESIPRAMINE HYDROXYLATION (CYTOCHROME P450-2D6) IN-VITRO BY QUINIDINE AND BY VIRAL PROTEASE INHIBITORS - RELATION TO DRUG-INTERACTIONS IN-VIVO
Authors: VONMOLTKE LL GREENBLATT DJ DUAN SX DAILY JP HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., INHIBITION OF DESIPRAMINE HYDROXYLATION (CYTOCHROME P450-2D6) IN-VITRO BY QUINIDINE AND BY VIRAL PROTEASE INHIBITORS - RELATION TO DRUG-INTERACTIONS IN-VIVO, Journal of pharmaceutical sciences, 87(10), 1998, pp. 1184-1189
COMPARATIVE KINETICS AND DYNAMICS OF ZALEPLON, ZOLPIDEM, AND PLACEBO
Authors: GREENBLATT DJ HARMATZ JS VONMOLTKE LL EHRENBERG BL HARREL L CORBETT K COUNIHAN M GRAF JA DARWISH M MERTZANIS P MARTIN PT CEVALLOS WH SHADER RI
Citation: Dj. Greenblatt et al., COMPARATIVE KINETICS AND DYNAMICS OF ZALEPLON, ZOLPIDEM, AND PLACEBO, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 553-561
KETOCONAZOLE INHIBITION OF TRIAZOLAM AND ALPRAZOLAM CLEARANCE - DIFFERENTIAL KINETIC AND DYNAMIC CONSEQUENCES
Authors: GREENBLATT DJ WRIGHT CE VONMOLTKE LL HARMATZ JS EHRENBERG BL HARREL LM CORBETT K COUNIHAN M TOBIAS S SHADER RI
Citation: Dj. Greenblatt et al., KETOCONAZOLE INHIBITION OF TRIAZOLAM AND ALPRAZOLAM CLEARANCE - DIFFERENTIAL KINETIC AND DYNAMIC CONSEQUENCES, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 237-247
INHIBITION OF TRIAZOLAM CLEARANCE BY MACROLIDE ANTIMICROBIAL AGENTS -IN-VITRO CORRELATES AND DYNAMIC CONSEQUENCES
Authors: GREENBLATT DJ VONMOLTKE LL HARMATZ JS COUNIHAN M GRAF JA DUROL ALB MERTZANIS P DUAN SX
Citation: Dj. Greenblatt et al., INHIBITION OF TRIAZOLAM CLEARANCE BY MACROLIDE ANTIMICROBIAL AGENTS -IN-VITRO CORRELATES AND DYNAMIC CONSEQUENCES, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 278-285
IMPAIRED CLEARANCE OF TRIAZOLAM BY MACROLIDE COADMINISTRATION - IN-VITRO CORRELATES AND CLINICAL CONSEQUENCES
Authors: GREENBLATT DJ VONMOLTKE LL HARMATZ JS WRIGHT CE HARREL L COUNIHAN M GRAF J MERTZANIS P SHADER RI
Citation: Dj. Greenblatt et al., IMPAIRED CLEARANCE OF TRIAZOLAM BY MACROLIDE COADMINISTRATION - IN-VITRO CORRELATES AND CLINICAL CONSEQUENCES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 42-42
REEVALUATION OF THE SPECIFICITY OF DEXTROMETHORPHAN AS AN INDEX SUBSTRATE
Authors: VONMOLTKE LL GREENBLATT DJ GRASSI JG GRANDA BW SCHMIDER J HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., REEVALUATION OF THE SPECIFICITY OF DEXTROMETHORPHAN AS AN INDEX SUBSTRATE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 80-80
PROTEASE INHIBITORS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - HIGH-RISK ASSOCIATED WITH RITONAVIR
Authors: VONMOLTKE LL GREENBLATT DJ GRASSI JG GRANDA BW DUAN SX DAILY JP HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., PROTEASE INHIBITORS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - HIGH-RISK ASSOCIATED WITH RITONAVIR, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 81-81
IN-VITRO APPROACHES TO PREDICTING DRUG-INTERACTIONS IN-VIVO
Authors: VONMOLTKE LL GREENBLATT DJ SCHMIDER J WRIGHT CE HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., IN-VITRO APPROACHES TO PREDICTING DRUG-INTERACTIONS IN-VIVO, Biochemical pharmacology, 55(2), 1998, pp. 113-122
HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO
Authors: VONMOLTKE LL GREENBLATT DJ DUAN SX SCHMIDER J WRIGHT CE HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO, Psychopharmacology, 132(4), 1997, pp. 402-407
INHIBITION OF CYP2C9 BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN-VITRO - STUDIES OF PHENYTOIN P-HYDROXYLATION
Authors: SCHMIDER J GREENBLATT DJ VONMOLTKE LL KARSOV D SHADER RI
Citation: J. Schmider et al., INHIBITION OF CYP2C9 BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN-VITRO - STUDIES OF PHENYTOIN P-HYDROXYLATION, British journal of clinical pharmacology, 44(5), 1997, pp. 495-498
BIOTRANSFORMATION OF CHLORZOXAZONE BY HEPATIC MICROSOMES FROM HUMANS AND 10 OTHER MAMMALIAN-SPECIES
Authors: COURT MH VONMOLTKE LL SHADER RI GREENBLATT DJ
Citation: Mh. Court et al., BIOTRANSFORMATION OF CHLORZOXAZONE BY HEPATIC MICROSOMES FROM HUMANS AND 10 OTHER MAMMALIAN-SPECIES, Biopharmaceutics & drug disposition, 18(3), 1997, pp. 213-226
METABOLISM OF DEXTROMETHORPHAN IN-VITRO - INVOLVEMENT OF CYTOCHROMES P450 2D6 AND 3A3 4, WITH A POSSIBLE ROLE OF 2E1/
Authors: SCHMIDER J GREENBLATT DJ FOGELMAN SM VONMOLTKE LL SHADER RI
Citation: J. Schmider et al., METABOLISM OF DEXTROMETHORPHAN IN-VITRO - INVOLVEMENT OF CYTOCHROMES P450 2D6 AND 3A3 4, WITH A POSSIBLE ROLE OF 2E1/, Biopharmaceutics & drug disposition, 18(3), 1997, pp. 227-240
ALPRAZOLAM HYDROXYLATION BY MOUSE-LIVER MICROSOMES IN-VITRO - THE EFFECT OF AGE AND PHENOBARBITAL INDUCTION
Authors: CHARPENTIER KP VONMOLTKE LL POKU JW HARMATZ JS SHADER RI GREENBLATT DJ
Citation: Kp. Charpentier et al., ALPRAZOLAM HYDROXYLATION BY MOUSE-LIVER MICROSOMES IN-VITRO - THE EFFECT OF AGE AND PHENOBARBITAL INDUCTION, Biopharmaceutics & drug disposition, 18(2), 1997, pp. 139-149
BIOTRANSFORMATION OF MESTRANOL TO ETHINYL ESTRADIOL IN-VITRO - THE ROLE OF CYTOCHROME-P-450 2C9 AND METABOLIC-INHIBITORS
Authors: SCHMIDER J GREENBLATT DJ VONMOLTKE LL KARSOV D VENA R FRIEDMAN HL SHADER RI
Citation: J. Schmider et al., BIOTRANSFORMATION OF MESTRANOL TO ETHINYL ESTRADIOL IN-VITRO - THE ROLE OF CYTOCHROME-P-450 2C9 AND METABOLIC-INHIBITORS, Journal of clinical pharmacology, 37(3), 1997, pp. 193-200
HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO
Authors: VONMOLTKE LL GREENBLATT DJ DUAN SX SCHMIDER J HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 48-48
VENLAFAXINE AND METABOLITES ARE VERY WEAK INHIBITORS OF HUMAN CYTOCHROME P450-3A ISOFORMS
Authors: VONMOLTKE LL DUAN SX GREENBLATT DJ FOGELMAN SM SCHMIDER J HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., VENLAFAXINE AND METABOLITES ARE VERY WEAK INHIBITORS OF HUMAN CYTOCHROME P450-3A ISOFORMS, Biological psychiatry, 41(3), 1997, pp. 377-380
PHENACETIN O-DEETHYLATION BY HUMAN LIVER-MICROSOMES IN-VITRO - INHIBITION BY CHEMICAL PROBES, SSRI ANTIDEPRESSANTS, NEFAZODONE AND VENLAFAXINE
Authors: VONMOLTKE LL DUAN SX KUDCHADKER L HARMATZ JS GREENBLATT DJ SCHMIDER J FOGELMAN SM SHADER RI
Citation: Ll. Vonmoltke et al., PHENACETIN O-DEETHYLATION BY HUMAN LIVER-MICROSOMES IN-VITRO - INHIBITION BY CHEMICAL PROBES, SSRI ANTIDEPRESSANTS, NEFAZODONE AND VENLAFAXINE, Psychopharmacology, 128(4), 1996, pp. 398-407
INHIBITION OF CYTOCHROME-P450 BY NEFAZODONE IN-VITRO - STUDIES OF DEXTROMETHORPHAN O-DEMETHYLATION AND N-DEMETHYLATION
Authors: SCHMIDER J GREENBLATT DJ VONMOLTKE LL HARMATZ JS SHADER RI
Citation: J. Schmider et al., INHIBITION OF CYTOCHROME-P450 BY NEFAZODONE IN-VITRO - STUDIES OF DEXTROMETHORPHAN O-DEMETHYLATION AND N-DEMETHYLATION, British journal of clinical pharmacology, 41(4), 1996, pp. 339-343
Risultati: 1-25 | 26-50 | 51-58